Valuation Metrics and Recent Changes
As of 13 Aug 2026, Insecticides India Ltd trades at a P/E ratio of 14.69 and a P/BV of 1.51. These figures represent a shift in valuation grade from very attractive to attractive, signalling a modest re-rating in the stock’s price levels relative to earnings and book value. The enterprise value to EBITDA (EV/EBITDA) stands at 8.94, which remains comparatively low within the pesticides and agrochemicals sector, suggesting the stock is still reasonably priced on an operational earnings basis.
While the P/E multiple has increased slightly, it remains well below the sector heavyweights such as Bayer CropScience and BASF India, which trade at P/E ratios of 25.27 and 27.74 respectively. This gap highlights Insecticides India’s valuation discount relative to larger peers, which may reflect its small-cap status and perceived risk profile.
Peer Comparison Highlights
Within the peer group, Insecticides India’s valuation is more attractive than several competitors. For instance, Anupam Rasayan and Laxmi Organic are classified as very expensive, with P/E ratios of 80.69 and 38.59 respectively. Conversely, Sharda Cropchem and Dhanuka Agritech are rated very attractive, trading at P/E multiples of 11.52 and 15.35. Insecticides India’s P/E of 14.69 places it comfortably in the attractive category, suggesting a reasonable entry point for value-focused investors.
EV/EBITDA multiples further reinforce this positioning. Insecticides India’s 8.94 multiple is lower than Bayer CropScience’s 19.06 and BASF India’s 17.61, indicating a more favourable valuation relative to earnings before interest, tax, depreciation and amortisation. This metric is particularly relevant in capital-intensive industries like agrochemicals, where operational cash flow generation is critical.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Financial Performance and Returns Analysis
Insecticides India’s return profile over various time horizons presents a mixed picture. The stock has underperformed the Sensex over the short and medium term, with a 1-year return of -38.82% compared to the Sensex’s -2.83%. Year-to-date, the stock is down 12.20%, while the Sensex has declined by 8.51%. However, over longer periods, the company has delivered respectable gains, with a 3-year return of 34.33% versus the Sensex’s 19.36%, and a 10-year return of 96.87% compared to the Sensex’s 176.94%.
This performance disparity highlights the stock’s volatility and sensitivity to sector-specific challenges, including commodity price fluctuations and regulatory changes impacting the pesticides and agrochemicals industry.
Profitability and Efficiency Metrics
Insecticides India’s latest return on capital employed (ROCE) stands at 16.04%, while return on equity (ROE) is 12.17%. These figures indicate a solid operational efficiency and reasonable shareholder returns, though they lag behind some of the more dominant players in the sector. The company’s dividend yield is modest at 0.32%, reflecting a conservative payout policy consistent with its growth and reinvestment strategy.
Market Capitalisation and Stock Movement
Classified as a small-cap stock, Insecticides India’s market capitalisation and liquidity constraints may contribute to its valuation discount. The stock closed at ₹627.10 on 13 Aug 2026, down 1.72% from the previous close of ₹638.10. The 52-week trading range spans from ₹525.90 to ₹1,070.10, indicating significant price volatility over the past year.
Today’s trading session saw a high of ₹639.10 and a low of ₹622.80, reflecting a narrow intraday range amid subdued market interest. This price action underscores the cautious sentiment prevailing among investors, likely influenced by the recent downgrade in the company’s mojo grade from Sell to Strong Sell on 12 Aug 2026.
Considering Insecticides India Ltd? Wait! SwitchER has found potentially better options in Pesticides & Agrochemicals and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - Pesticides & Agrochemicals + beyond scope
- - Top-rated alternatives ready
Valuation Outlook and Investor Considerations
The recent upgrade in valuation grade from very attractive to attractive suggests that the stock’s price has risen relative to earnings and book value, potentially reflecting improved investor confidence or sector tailwinds. However, the downgrade in mojo grade to Strong Sell signals caution, as the company faces challenges that may impact near-term performance.
Investors should weigh the company’s attractive valuation multiples against its recent underperformance and sector risks. The relatively low P/E and EV/EBITDA ratios compared to peers offer a margin of safety, but the stock’s small-cap status and volatile returns warrant a careful approach.
Comparing Insecticides India with other small-cap peers such as Sharda Cropchem and Dhanuka Agritech, which maintain very attractive valuations and stronger mojo grades, may provide alternative investment opportunities within the pesticides and agrochemicals sector.
Conclusion
Insecticides India Ltd’s valuation parameters have shifted to a more attractive level, supported by reasonable P/E and EV/EBITDA multiples relative to its peer group. Despite this, the stock’s recent price decline, downgrade to Strong Sell, and underwhelming short-term returns highlight ongoing challenges. Investors should consider these factors carefully, balancing valuation appeal with operational and market risks before making investment decisions.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
